Lactosylated poly(ethylene oxide)–poly(propylene oxide) block copolymers for potential active targeting: synthesis and physicochemical and self-aggregation characterization
Source abstract
Abstract
Aiming to develop polymeric self-assem- bly nanocarriers with potential applications in active drug targeting to the liver, linear and branched poly(ethylene oxide)-poly(propylene oxide) amphi- philes were conjugated to lactobionic acid (LA), a disaccharide of galactose and gluconic acid, by the conventional Steglich esterification reaction. The conjugation was confirmed by ATR/FT-IR, 1 H-NMR, and 13 C-NMR spectroscopy. Elemental analysis and MALDI-TOF mass spectrometry were employed to elucidate the conjugation extent and the final molec- ular weight, respectively. The critical micellar con- centration (CMC), the size and size distribution and zeta potential of the pristine and modified polymeric micelles under different conditions of pH and temper- ature were characterized by dynamic light scattering (DLS). Conjugation with LA favored the micellization process, leading to a decrease of the CMC with respect to the pristine counterpart, this phenomenon being independent of the pH and the temperature. At 37 C, micelles made of pristine copolymers showed a monomodal size distribution between 12.8 and 24.4 nm. Conversely, LA-conjugated micelles showed a bimodal size pattern that comprised a main fraction of relatively small size (11.6-22.2 nm) and a second one with remarkably larger sizes of up to 941.4 nm. The former corresponded to single micelles, while the latter would indicate a secondary aggregation phenomenon. The spherical morphology of LA-micelles was visualized by transmission elec- tron microscopy (TEM). Finally, to assess the ability of the LA-conjugated micelles to interact with lectin- like receptors, samples were incubated with conca- navalin A at 37 C and the size and size distribution were monitored by DLS. Findings indicated that regardless of the relatively weak affinity of this vegetal lectin for galactose, micelles underwent agglutination probably through the interaction of a secondary site in the lectin with the gluconic acid unit of LA.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Advanced Drug Delivery Systems · Nanoparticle-Based Drug Delivery · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (61)
Show source-provided references
1. Alvarez-Lorenzo C, Rey-Rico A, Brea J, Loza MI, Concheiro A, Sosnik A (2010) Inhibition of P-glycoprotein pumps by PEO–PPO amphiphiles: branched versus linear derivatives. Nanomedicine (Lond.) 5:1571–158310.2217/nnm.10.53 ↗
2. Alvarez-Lorenzo C, Sosnik A, Concheiro A (2011) PEO–PPO block copolymers for passive micellar targeting and overcoming multidrug resistance in cancer therapy. Curr Drug Targets 12:1112–113010.2174/138945011795906615 ↗
3. Bootz A, Russ T, Gores F, Karas M, Kreuter J (2005) Molecular weights of poly(butyl cyanoacrylate) nanoparticles determined by mass spectrometry and size exclusion chromatography. Eur J Pharm Biopharm 60:391–39910.1016/j.ejpb.2005.02.009 ↗
4. Casali M, Riva S, Ferruti P (2001) Use of new aminosugar derivatives as co-monomers for the synthesis of glycosylated poly(amido-amines). J Bioact Comp Polym 16:479–49110.1106/470Q-MBQN-RN2Y-LB5L ↗
5. Chen Y, Cui G, Zhao M, Wang C, Qian K, Morris-Natsche S, Lee KH, Peng S (2008) Synthesis, nano-scale assembly, and in vivo anti-thrombotic activity of novel short peptides containing L-Arg and L-Asp or L-Glu. Bioorg Med Chem 16:5914–592510.1016/j.bmc.2008.04.064 ↗
6. Chiappetta DA, Sosnik A (2007) Poly(ethylene oxide)–poly(propylene oxide) block copolymer micelles as drug delivery agents: improved hydrosolubility, stability and bioavailability of drugs. Eur J Pharm Biopharm 66:303–31710.1016/j.ejpb.2007.03.022 ↗
7. Chiappetta DA, Degrossi J, Teves S, D′Aquino M, Bregni C, Sosnik A (2008) Triclosan-loaded poloxamine micelles for enhanced antibacterial activity against biofilm. Eur J Pharm Biopharm 69:535–54510.1016/j.ejpb.2007.11.021 ↗
8. Chiappetta DA, Alvarez-Lorenzo C, Rey-Rico A, Taboada P, Concheiro A, Sosnik A (2010) N-alkylation of poloxamines modulates micellar encapsulation and release of the antiretroviral efavirenz. Eur J Pharm Biopharm 76:24–3710.1016/j.ejpb.2010.05.007 ↗
9. Chiappetta DA, Facorro G, Rubin de Celis E, Sosnik A (2011) Synergistic encapsulation of the anti-HIV agent efavirenz within mixed poloxamine/poloxamer polymeric micelles. Nanomedicine: NBM 7:624–63710.1016/j.nano.2011.01.017 ↗
10. Chiappetta DA, Hocht C, Opezzo JAW, Sosnik A (2013) Intranasal administration of antiretroviral-loaded micelles for anatomical targeting to the brain in HIV. Nanomedicine (Lond.) 1–1510.2217/nnm.12.104 ↗
11. Choi YH, Liu F, Park JS, Kim SW (1998) Lactose-poly(ethylene glycol)-grafted poly-l-lysine as hepatoma cell-targeted gene carrier. Bioconj Chem 9:708–71810.1021/bc980017v ↗
12. Cohn D, Sosnik A, Levy A (2003) Improved reverse thermo-responsive polymeric systems. Biomaterials 24:3707–371410.1016/S0142-9612(03)00245-X ↗
13. Cohn D, Sosnik A, Garty S (2005) Smart hydrogels for in situ-generated implants. Biomacromolecules 6:1168–117510.1021/bm0495250 ↗
14. Cohn D, Lando G, Sosnik A, Garty S, Levi A (2006) Novel degradable reverse thermoresponsive multiblock copolymers. Biomaterials 27:1718–172710.1016/j.biomaterials.2005.10.035 ↗
15. Cuestas ML, Mathet VL, Oubiña JR, Sosnik A (2010) Drug delivery systems and liver targeting for the improved pharmacotherapy of the hepatitis B virus (HBV) infection. Pharm Res 27:1184–120210.1007/s11095-010-0112-z ↗
16. De Paula D, Bentley VLB, Mahato RI (2007) Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting. RNA 13:431–45610.1261/rna.459807 ↗
17. Eisenburg C, Seta N, Appel M, Feldmann G, Durand G, Feger J (1991) Asialoglycoprotein receptor in human isolated heaptocytes from normal liver and its apparent increase in liver with histological alterations. J Hepatol 13:305–30910.1016/0168-8278(91)90073-K ↗
18. El-Seraq HB, Rudolph KL (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132:2557–257610.1053/j.gastro.2007.04.061 ↗
19. Enrich C, Verges M, Evans WH (1992) Differential expression of asialoglycoprotein receptor subunits in the endocytic compartment during liver regeneration. J Cell Physiol 150:344–35210.1002/jcp.1041500218 ↗
20. Eto T, Takahashi H (1999) Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon. Nat Med 5:577–58110.1038/8462 ↗
21. Feng M, Cai Q, Shi X, Huang H, Zhou P, Guo X (2008) Recombinant high-density lipoprotein complex as targeting system of nosiheptide to liver cells. J Drug Target 16:502–50810.1080/10611860802200938 ↗
22. Fernandez-Tarrio M, Alvarez-Lorenzo C, Concheiro A (2007) Calorimetric approach to Tetronic/water interactions. J Therm Anal Calorim 87:171–17810.1007/s10973-006-7834-5 ↗
23. Fiume L, Busi C, Di Stefano G, Mattioli A (1994) Targeting of antiviral drugs to the liver using glycoprotein carriers. Adv Drug Del Rev 14:51–6510.1016/0169-409X(94)90005-1 ↗
24. Gallet G, Carroccio S, Rizzarelli P, Karlsson S (2002) Thermal degradation of poly(ethylene oxide-propylene oxide-ethylene oxide) triblock copolymer: comparative study by SEC/NMR, SEC/MALDI-TOF-MS and SPME/GC-MS. Polymer 43:1081–109410.1016/S0032-3861(01)00677-2 ↗
25. Gao S, Chen J, Xu X, Ding Z, Yang Y-H, Hua Z, Zhang J (2003) Galactosylated low molecular weight chitosan as DNA carrier for hepatocyte-targeting. Int J Pharm 255:57–6810.1016/S0378-5173(03)00082-6 ↗
26. Giacomelli C, Schmidt V, Borsali R (2007) Nanocontainers formed by self-assembly of poly(ethylene oxide)-b-poly(glycerol monomethacrylate)-drug conjugates. Macromolecules 40:2148–215710.1021/ma062562u ↗
27. Glisoni RJ, Chiappetta DA, Finkielstein LM, Moglioni AG, Sosnik A (2010) Self-aggregation behaviour of novel thiosemicarbazone drug candidates with potential antiviral activity. New J Chem 34:2047–205810.1039/c0nj00061b ↗
28. Glisoni RJ, Chiappetta DA, Moglioni AG, Sosnik A (2012a) Novel 1-indanone thiosemicarbazone antiviral candidates: aqueous solubilization and physical stabilization by means of cyclodextrins. Pharm Res 29:739–75510.1007/s11095-011-0599-y ↗
29. Glisoni RJ, Cuestas ML, Mathet V, Oubiña J, Moglioni AG, Sosnik A (2012b) Antiviral activity against the hepatitis C virus (HCV) of 1-indanone thiosemicarbazones and their inclusion complexes with hydroxypropyl-β-cyclodextrin. Eur J Pharm Sci 47:596–60310.1016/j.ejps.2012.07.018 ↗
30. Gonzalez-Lopez J, Alvarez-Lorenzo C, Taboada P, Sosnik A, Sandez-Macho I, Concheiro A (2008) Self-associative behavior and drug-solubilizing ability of poloxamine (tetronic) block copolymers. Langmuir 24:10688–1069710.1021/la8016563 ↗
31. Guidotti LG, Chisari FV (2006) Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol Mech Dis 1:23–6110.1146/annurev.pathol.1.110304.100230 ↗
32. Gupta U, Jain NK (2010) Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting. Adv Drug Deliv Rev 62:478–49010.1016/j.addr.2009.11.018 ↗
33. Kataoka K, Harada A, Nagasaki Y (2001) Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev 47:113–13110.1016/S0169-409X(00)00124-1 ↗
34. Kikker R, Lepenies B, Dibekian A, Laurino P, Seeberger PH (2009) In vitro imaging and in vivo liver targeting with carbohydrate capped quantum dots. J Am Chem Soc 131:2110–211210.1021/ja807711w ↗
35. Kim TH, Park IK, Nah JW (2004) Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier. Biomaterials 25:3783–379210.1016/j.biomaterials.2003.10.063 ↗
36. Kim SI, Shin D, Lee H, Ahn BY, Yoon Y, Kim M (2009) Targeted delivery of siRNA against hepatitis C virus by apolipoprotein A-I-bound cationic liposomes. J Hepatol 50:479–48810.1016/j.jhep.2008.10.029 ↗
37. Li Y, Huang G, Diakur J, Wiebe LI (2008) Targeted delivery of macromolecular drugs: asialoglycoprotein receptor (ASPGR) expression by selected hepatoma cell lines used in antiviral drug development. Curr Drug Deliv 5:299–30210.2174/156720108785915069 ↗
38. Li X, Huang Y, Chen X, Zhou Y, Zhang Y, Li P, Liu Y, Sun Y, Zhao J, Wang F (2009) Self-assembly and characterization of Pluronic P105 micelles for liver-targeted delivery of silybin. J Drug Target 17:739–75010.3109/10611860903062062 ↗
39. Li Y, Hoskins JN, Sreerama SG, Grayson MA, Grayson SM (2010) The identification of synthetic homopolymer end groups and verification of their transformations using MALDI-TOF mass spectrometry. J Mass Spectrom 45:587–61110.1002/jms.1743 ↗
40. Lu C, Chen X, Xie Z, Lu T, Wang X, Ma J, Jing X (2006) Biodegradable amphiphilic triblock copolymer bearing pendant glucose residues: preparation and specific interaction with concanavalin A molecules. Biomacromolecules 7:1806–181010.1021/bm0601225 ↗
41. Mao SJ, Bi YQ, Jin H, Wei DP, He R, Hou SX (2007) Preparation, characterization and uptake by primary cultured rat hepatocytes of liposomes surface-modified with glycyrrhetinic acid. Pharmazi 62:614–619
42. Meng-Xin H, Zhi-Kang X (2011) Carbohydrate decoration of microporous polypropylene membranes for lectin affinity adsorption: comparison of mono- and disaccharides. Colloids Surf B 85:19–2510.1016/j.colsurfb.2010.10.030 ↗
43. Nishina K, Unno T, Uno Y, Kubodera T, Kanouchi T, Mizusawa H, Yokota T (2008) Efficient in vivo delivery of siRNA to the liver by conjugation of α-tocopherol. Mol Ther 16:734–74010.1038/mt.2008.14 ↗
44. Raith K, Schmelzer CEH, Neubert RHH (2006) Towards a molecular characterization of pharmaceutical excipients: mass spectrometric studies of ethoxylated surfactants. Int J Pharm 319:1–1210.1016/j.ijpharm.2006.03.030 ↗
45. Sato Y, Murase K, Kato J, Kobune M, Sato T, Kawano Y, Takimoto R, Takada K, Miyanishi K, Matsunaga T, Takayama T, Niitsu Y (2008) Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone. Nat Biotechnol 26:431–44210.1038/nbt1396 ↗
46. Sosnik A, Cohn D (2003) Poly(ethylene glycol)–poly(epsilon-caprolactone) block oligomers as injectable materials. Polymer 44:7033–704210.1016/j.polymer.2003.09.012 ↗
47. Sosnik A, Cohn D (2005) Reverse thermo-responsive poly(ethylene oxide) and poly(propylene oxide) multiblock copolymers. Biomaterials 26:349–35710.1016/j.biomaterials.2004.02.041 ↗
48. Sosnik A, Sefton MV (2006) Methylation of poloxamine for enhanced cell adhesion. Biomacromolecules 7:331–33810.1021/bm050693h ↗
49. Sosnik A, Brodersen P, Sodhi RNS, Sefton MV (2006) Surface study of collagen/poloxamine hydrogels by a ‘deep freezing’ ToF-SIMS approach. Biomaterials 27:2340–234810.1016/j.biomaterials.2005.11.028 ↗
50. Sosnik A, Carcaboso A, Chiappetta DA (2008) Polymeric nanocarriers: new endeavors for the optimization of the technological aspects of drugs. Recent Pat Biomed Eng 1:43–5910.2174/1874764710801010043 ↗
51. Tozawa R, Ishibashi S, Osuga J, Yamamoto K, Yagyu H, Ohashi K, Tamura Y, Yahagi N, Iizuka Y, Okazaki H, Harada K, Gotoda T, Shimano H, Kimura S, Nagai R, Yamada N (2001) Asialoglycoprotein receptor deficiency in mice lacking the major receptor subunit. Its obligate requirement for the stable expression of oligomeric receptor. J Biol Chem 276:12624–1262810.1074/jbc.M011063200 ↗
52. Trevaskis NL, Charman WN, Porter CJH (2010) Targeted drug delivery to lymphocytes: a route to site-specific immunomodulation? Mol Pharm 7:2297–230910.1021/mp100259a ↗
53. Vetri V, Carrotta R, Picone P, Di Carlo M, Militello V (2010) Concanavalin A aggregation and toxicity on cell cultures. Biochim Biophys Acta 1804:173–18310.1016/j.bbapap.2009.09.013 ↗
54. Wang S, Deng Y, Xu H (2006) Synthesis of a novel galactosylated lipid and its application to the hepatocyte-selective targeting of liposome doxorubicin. Eur J Pharm Biopharm 62:32–3810.1016/j.ejpb.2005.07.004 ↗
55. Wang Z, Yuan Z, Jin L (2008) Gene delivery into hepatocytes with the preS/liposome/DNA system. Biotechnol J 3:1286–129510.1002/biot.200800125 ↗
56. Wang X, Liu LH, Ramström O, Yan M (2009) Engineering nanomaterial surfaces for biomedical applications. Exp Biol Med 234:1128–113910.3181/0904-MR-134 ↗
57. Wang X, Ramström O, Yan M (2011) Dynamic light scattering as an efficient tool to study glyconanoparticle–lectin interactions. Analyst 136:4174–417810.1039/c1an15469a ↗
58. Weeke-Klimp AH, Bartsch M, Morselt HW, Van Veen-Hof I, Meijer DK, Scherphof GL, Kamps JA (2007) Targeting of stabilized plasmid lipid particles to hepatocytes in vivo by means of coupled lactoferrin. J Drug Target 15:585–59410.1080/10611860701502889 ↗
59. Wu GY, Wu CH (1998) Receptor mediated delivery of foreign genes to hepatocytes. Adv Drug Deliv Rev 29:243–24810.1016/S0169-409X(97)00082-3 ↗
60. Yang J, Bo XC, Ding XR, Dai JM, Zhang ML, Wang XH, Wang SQ (2006) Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication. J Viral Hepat 13:158–16510.1111/j.1365-2893.2005.00666.x ↗
61. Zhang J, Li C, Cheng HW, Xue ZY, Huang FW, Zhuo RX, Zhang XZ (2011) Fabrication of lactobionic-loaded chitosan microcapsules as potential drug carriers targeting the liver. Acta Biomater 7:1655–1673